The 4Kscore Test as a Predictor of High-Grade Prostate Cancer

Video

Raoul S. Concepcion, MD, FACS, Urology Associates P.C., discusses the potential for the 4Kscore test as a predictor of high-grade prostate cancer.

Clinical Pearls

Raoul S. Concepcion, MD, FACS, Urology Associates P.C., discusses the potential for the 4Kscore test as a predictor of high-grade prostate cancer.

  • There remains a need for a way for physicians to determine which prostate cancer patients need to be biopsied and if the detected tumor is high-grade.
  • An early study of about 1000 patients analyzed the 4Kscore test in this space.
  • The 4Kscore test, with certain limits, may be able to predict higher-grade cancers. This test could reduce the number of biopsies without missing a significant number of high-grade tumors.
Related Videos
Video 8 - "Clinical Pearls for Optimal Management of mHSPC"
Video 7 - "Multidisciplinary Approach in mHSPC Management "
Video 6 - "Treatment Considerations in High Disease Burden and Comorbidities"
Video 5 - "Pivotal Trials in mHSPC"
Video 4 - "ARASENS Trial- Darolutamide in mHSPC"
Video 3 - "Treatment Intensification in Metastatic Prostate Cancer"
Video 2 - "Treatment Options for mHSPC"
Video 1 - "Initial Impression and Risk Assessment"
Related Content
Skin Cancer Awareness Month: Sun Safety and Tackling Diagnosis

Skin Cancer Awareness Month: Sun Safety and Tackling Diagnosis

May 15th 2024
Article

For Melanoma and Skin Cancer Awareness Month, Nayoung Lee, MD, discussed evolving paradigms in skin cancer diagnosis and prevention.

Read More

LaPelusa’s Journey in the Dynamic Field of GI Oncology

LaPelusa’s Journey in the Dynamic Field of GI Oncology

May 1st 2024
Podcast

In this episode of Emerging Experts, Michael LaPelusa, MD, shares his insights, experiences, and passion for cancer research, particularly in the realm of gastrointestinal cancers.

Listen

Expanding 177Lutetium-PSMA-617 Use in the Community

Expanding 177Lutetium-PSMA-617 Use in the Community

May 12th 2024
Article

Training at a major academic center offers firsthand exposure to groundbreaking 177Lu-PSMA-617 treatment for advanced prostate cancer.

Read More

The Future of Breast Cancer Care: Blackwood on Personalized Approaches

The Future of Breast Cancer Care: Blackwood on Personalized Approaches

April 15th 2024
Podcast

In this episode of Targeted Talks, M. Michele Blackwood, MD, FACS, discusses the current landscape of breast cancer treatment and how personalized medicine with genomic testing is changing the field.

Listen

CAPTURE Trial Reveals BRCA Mutations Linked to Worse Outcomes in mCRPC

CAPTURE Trial Reveals BRCA Mutations Linked to Worse Outcomes in mCRPC

May 10th 2024
Article

Those with metastatic castration-resistant prostate cancer in the BRCA subgroup experienced worse outcomes vs those in non-BRCA subgroups, according to the results of the CAPTURE trial.

Read More

Advancing Care in Urothelial Carcinoma With the MAIN-CAV Trial

Advancing Care in Urothelial Carcinoma With the MAIN-CAV Trial

May 9th 2024
Article

In an interview with Targeted Oncology, Shilpa Gupta, MD, discussed the rationale and potential significance of the MAIN-CAV trial in patients with locally advanced/metastatic urothelial carcinoma.

Read More